How Can We Help?
Skip to content
Researcher looking at a book

Drug Metabolizing Enzymes and Transporters in NASH

  • Published on February 15, 2017
  • Disease-Specific Resources
  • Drug Drug Interactions (DDI)
  • Drug Metabolism
  • Webinars

“Drug Metabolizing Enzymes and Transporters in NASH: Research Application of Variants of Fatty Liver Disease (FLD) Tissues”

Presented by Maciej Czerwinski, Ph.D., SEKISUI XenoTech Director of Consulting

Abstract:

SEKISUI XenoTech is committed to the support of research into human diseases, particularly of the liver. In the course of over twenty years of pharmacokinetic studies in human hepatocytes, we have accumulated normal and diseased tissues representing FLD with or without history of excessive alcohol consumption and steatohepatitis. In this webinar, characteristics of the FLD and the effects of the condition on drug metabolism and disposition will be outlined.

Key concepts discussed:

  • Fatty liver disease – characterization and progression
  • Effects of fatty liver diseases on drug metabolism and transport
  • Organ collection procedures
  • Specimen storage
  • Characterization
  • Features of tissue from donors with and without significant consumption of alcohol, T2 and T1DM and pediatric donors

Download Slides

What topic would you like to hear about?

Our experts are constantly on the hunt for new and exciting topics to present on, and nothing helps us figure out what you want to hear more than requests and feedback! Use our form to submit your request so we can continue producing educational materials you look forward to

Access ADME